Bellevue Life Sciences Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering
February 10, 2023
BELLEVUE, Wash.,Feb. 10, 2023/PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. (the "Company") today announced the pricing of its initial public offering of 6,000,000 units at a price of$10.00per unit. The units will be listed on The Nasdaq Capital Market ("Nasdaq") and trade under the ticker symbol "BLACU" beginning onFebruary 10, 2023. Each unit consists of one share of common stock, one redeemable warrant and one right, with each right entitling the holder thereof to receive one-tenth of one share of common stock upon consummation of an initial business combination. After the securities comprising the units begin separate trading, the shares of common stock, warrants and rights are expected to be listed on Nasdaq under the symbols "BLAC," "BLACW" and "BLACR," respectively. The offering is expected to close onFebruary 14, 2023, subject to customary closing conditions.
Thank You!
We've received your information, and we're processing your request.